Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory J Cost

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Genome Research|July 4, 2014
Efficient gene targeting by homology-directed repair in rat zygotes using TALE nucleasesSéverine Remy, Laurent Tesson, Séverine Menoret, et al.
Stem Cell Reports|June 18, 2014
Human intestinal tissue with adult stem cell properties derived from pluripotent stem cellsRyan Forster, Kunitoshi Chiba, Lorian Schaeffer, et al.
Nucleic Acids Research|June 10, 2010
Zinc-finger nuclease-driven targeted integration into mammalian genomes using donors with limited chromosomal homologySalvatore J Orlando, Yolanda Santiago, Russell C DeKelver, et al.
The CRISPR Journal|May 23, 2023
Novel CRISPR-Associated Gene-Editing Systems Discovered in Metagenomic Samples Enable Efficient and Specific Genome EngineeringRebecca C Lamothe, Meghan D Storlie, Diego A Espinosa, et al.
Nature Biotechnology|July 9, 2011
Genetic engineering of human pluripotent cells using TALE nucleasesDirk Hockemeyer, Haoyi Wang, Samira Kiani, et al.
Nature Communications|December 15, 2022
Compact Cas9d and HEARO enzymes for genome editing discovered from uncultivated microbesDaniela S Aliaga Goltsman, Lisa M Alexander, Jyun-Liang Lin, et al.
Nature|July 19, 2013
Translating dosage compensation to trisomy 21Jun Jiang, Yuanchun Jing, Gregory J Cost, et al.
Nature Biotechnology|December 24, 2010
A TALE nuclease architecture for efficient genome editingJeffrey C Miller, Siyuan Tan, Guijuan Qiao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 15, 2026
Preclinical efficacy and safety assessment of engineered regulatory T cells for treatment of IPEX and other autoimmune disordersYuchi Honaker, Noelle P Dahl, Swati Singh, et al.
The CRISPR Journal|June 5, 2023
Novel and Engineered Type II CRISPR Systems from Uncultivated Microbes with Broad Genome Editing CapabilityLisa M Alexander, Daniela S Aliaga Goltsman, Jason Liu, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Genome Research|July 4, 2014
Efficient gene targeting by homology-directed repair in rat zygotes using TALE nucleasesSéverine Remy, Laurent Tesson, Séverine Menoret, et al.
Stem Cell Reports|June 18, 2014
Human intestinal tissue with adult stem cell properties derived from pluripotent stem cellsRyan Forster, Kunitoshi Chiba, Lorian Schaeffer, et al.
Nucleic Acids Research|June 10, 2010
Zinc-finger nuclease-driven targeted integration into mammalian genomes using donors with limited chromosomal homologySalvatore J Orlando, Yolanda Santiago, Russell C DeKelver, et al.
The CRISPR Journal|May 23, 2023
Novel CRISPR-Associated Gene-Editing Systems Discovered in Metagenomic Samples Enable Efficient and Specific Genome EngineeringRebecca C Lamothe, Meghan D Storlie, Diego A Espinosa, et al.
Nature Biotechnology|July 9, 2011
Genetic engineering of human pluripotent cells using TALE nucleasesDirk Hockemeyer, Haoyi Wang, Samira Kiani, et al.
Nature Communications|December 15, 2022
Compact Cas9d and HEARO enzymes for genome editing discovered from uncultivated microbesDaniela S Aliaga Goltsman, Lisa M Alexander, Jyun-Liang Lin, et al.
Nature|July 19, 2013
Translating dosage compensation to trisomy 21Jun Jiang, Yuanchun Jing, Gregory J Cost, et al.
Nature Biotechnology|December 24, 2010
A TALE nuclease architecture for efficient genome editingJeffrey C Miller, Siyuan Tan, Guijuan Qiao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 15, 2026
Preclinical efficacy and safety assessment of engineered regulatory T cells for treatment of IPEX and other autoimmune disordersYuchi Honaker, Noelle P Dahl, Swati Singh, et al.
The CRISPR Journal|June 5, 2023
Novel and Engineered Type II CRISPR Systems from Uncultivated Microbes with Broad Genome Editing CapabilityLisa M Alexander, Daniela S Aliaga Goltsman, Jason Liu, et al.
Pageof 4